Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2

Status

Completed 4

Sponsor Class

INDUSTRY 2OTHER 1INDIV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 16Lymphoid 6Thoracic 4Classical hematology 4Other hematologic neoplasm 2Gynecologic 2Sarcoma 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 9Ovarian Neoplasms 5Neutropenia 4Breast Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Adenocarcinoma of Lung 4Small Cell Lung Carcinoma 3Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Previously Treated Non Small Cell Lung Cancer 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Fever 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1Anemia 1

Interventions

pegfilgrastim 4pegylated granulocyte colony-stimulating factor 2trilaciclib 1Vitamin B 12 1PM 01183 1Folic Acid 1Docetaxel 1Darbepoetin alfa 1Cisplatin 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neutropenia × pegfilgrastim × Thoracic × Clear all
NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
160 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Amgen

Phase 4 Completed
852 enrolled
BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Amgen

Phase 4 Completed
Thoracic

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡